Download our technology overview flyer and our recent poster presentations to see the impact of Retrogenix’s target deconvolution, receptor identification and off-target screening work.

Confirm target specificity/ uncover off-targets

This poster presents data from two off-target screens showing how the Retrogenix approach rapidly identifies specific and relevant off-targets with a very low rate of false positive results. The first study demonstrates target specificity and the second uncovers a previously unidentified, critical off-target…

Download Now

Technology overview

Download our receptor identification and off-target profiling flyer for an overview of the applications of the Retrogenix cell microarray technology. Further details of how the technology is currently being used by industry and academia can be found by browsing the ‘recent publications’ section of the website.


Download Now

CAR T cell specificity screening poster

Download our SOT 2017 poster describing the how the Retrogenix human cell microarray technology has been optimised to screen whole CAR T cells for specific interactions, reducing the risk of unanticipated off-target adverse effects in the development of novel immunotherapies and providing essential supporting data for pre-IND safety assessment.

Download Now



Immune checkpoint poster

Download a recent poster presented at PEGS Boston to see some typical results from a cell microarray screen and learn how the Retrogenix technology can assist with immune checkpoint pairing.

Further examples of the applications of the cell microarray technology can also be found in the case studies resource on this website.

Download Now

Antibody off-target screening poster

Biologics such as antibodies are widely favoured in drug discovery due to their inherent potential for specificity to a single target antigen. Despite this, off-target mediated toxicity could present an issue for a subset of antibodies and other molecules in development. Download our PEGS 2017 poster to learn how the Retrogenix human cell microarray technology approach is being applied to identify specific and relevant off-targets with a very low rate of false positive results.

Download Now

Watch our animation

Retrogenix expresses thousands of full-length human plasma membrane proteins in the context of human cells in order to detect relevant interactions with test molecules.

The animation on this website provides an overview of how we set up the cell microarrays and use the technology to identify primary receptors targets and off-targets for a wide variety of ligands.

View animation

The University of Sheffield
Aveo Oncology - The Human Response
Theraclone Sciences
Bluebird Bio
The Center for Infectious Disease Research
Compugen Logo
The University of Copenhagen
Lund University
NIH - National Institutes of Health
The University of Pennsylvania
Scripps Florida - The Scripps Research Institute
Peptinnovate Ltd - Unlocking Nature's Potential
We’ve developed a terrific working relationship with the team at Retrogenix and intend to utilize their microarray technology as a standard screen for future targets. Jim and Jo have become trusted collaborators and we appreciate their flexibility and willingness to work with us through some challenging issues. The quality and timeliness of the data and reports are first rate. We’ve come to rely on their results as a dependable means to confirm results from traditional crossreactivity studies and to identify additional potential unexpected interactions.
Amy Bourdeau, ‎Senior Preclinical Development Coordinator, Bluebird bio